Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
$0.00
$0.00
$0.51
$2.05
$111KN/A136,653 shs1,000 shs
EMCOR Group, Inc. stock logo
EME
EMCOR Group
$535.42
+0.9%
$462.11
$319.49
$545.30
$23.75B1.23450,566 shs421,465 shs
PetroChina Company Limited stock logo
PTR
PetroChina
$45.70
$41.48
$57.87
$85.75B0.61217,309 shs4,678 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00%0.00%0.00%0.00%0.00%
EMCOR Group, Inc. stock logo
EME
EMCOR Group
+0.85%+8.10%+13.63%+42.74%+46.66%
PetroChina Company Limited stock logo
PTR
PetroChina
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
3.7274 of 5 stars
2.44.02.50.02.92.51.9
PetroChina Company Limited stock logo
PTR
PetroChina
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
0.00
N/AN/AN/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
2.82
Moderate Buy$518.00-3.25% Downside
PetroChina Company Limited stock logo
PTR
PetroChina
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest PTR, EME, CLON, and AST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
6/27/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/27/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/27/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
Hovde Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
6/27/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
6/27/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$560.00
6/13/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$570.00
5/1/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$514.00 ➝ $503.00
(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/AN/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
$14.57B1.65$25.02 per share21.40$63.88 per share8.38
PetroChina Company Limited stock logo
PTR
PetroChina
$405.22B0.00N/A1.71$119.32 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/A0.00N/AN/AN/AN/AN/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
$1.01B$22.6323.6624.07N/A7.00%37.12%14.01%7/24/2025 (Estimated)
PetroChina Company Limited stock logo
PTR
PetroChina
$14.29B$10.174.610.00N/A4.00%8.46%4.66%N/A

Latest PTR, EME, CLON, and AST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
$5.68N/AN/AN/A$4.10 billionN/A
4/30/2025Q1 2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
$4.57$5.41+$0.84$5.26$3.78 billion$3.87 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/AN/AN/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
$1.000.19%N/A4.42%5 Years
PetroChina Company Limited stock logo
PTR
PetroChina
$2.555.44%N/A25.07%N/A

Latest PTR, EME, CLON, and AST Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/8/2025
EMCOR Group, Inc. stock logo
EME
EMCOR Group
quarterly$0.250.3%4/17/20254/17/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/AN/AN/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
0.08
1.16
1.14
PetroChina Company Limited stock logo
PTR
PetroChina
0.16
1.00
0.71

Institutional Ownership

CompanyInstitutional Ownership
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
92.59%
PetroChina Company Limited stock logo
PTR
PetroChina
0.26%

Insider Ownership

CompanyInsider Ownership
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A
EMCOR Group, Inc. stock logo
EME
EMCOR Group
1.26%
PetroChina Company Limited stock logo
PTR
PetroChina
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Asterias Biotherapeutics Inc stock logo
AST
Asterias Biotherapeutics
N/A55.66 millionN/ANot Optionable
EMCOR Group, Inc. stock logo
EME
EMCOR Group
40,40044.76 million44.19 millionOptionable
PetroChina Company Limited stock logo
PTR
PetroChina
417,1731.83 billionN/AOptionable

Recent News About These Companies

PetroChina to shoot 3D seismic survey offshore Suriname
PetroChina Boasts Stable Growth in Q1 2025
PetroChina records 2.3% rise in Q1 profit
PetroChina posts mixed Q1 2025 results amid weak oil prices

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Asterias Biotherapeutics stock logo

Asterias Biotherapeutics NYSEAMERICAN:AST

$0.0020 0.00 (0.00%)
As of 07/10/2019

Asterias Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing cell-based therapeutics to treat neurological conditions associated with demyelination, and cellular immunotherapies to treat cancer. Its clinical stage programs include AST-OPC1, an oligodendrocyte progenitor cell population derived from pluripotent stem cells that is in Phase I/IIa clinical trial for spinal cord injuries; AST-VAC2 is a non-patient-specific cancer immunotherapy derived from pluripotent stem cells for the treatment of non-small cell lung cancer; and AST-VAC1, a patient-specific cancer immunotherapy that has completed Phase II clinical trial for the treatment of acute myeloid leukemia. The company was formerly known as BioTime Acquisition Corporation and changed its name to Asterias Biotherapeutics, Inc. in March 2013. Asterias Biotherapeutics, Inc. was founded in 2012 and is headquartered in Fremont, California.

EMCOR Group stock logo

EMCOR Group NYSE:EME

$535.42 +4.80 (+0.90%)
As of 06/30/2025 03:58 PM Eastern

EMCOR Group, Inc. provides construction and facilities, building, and industrial services in the United States and the United Kingdom. It offers design, integration, installation, start-up, operation, and maintenance services related to power transmission, distribution, and generation systems; energy solutions; premises electrical and lighting systems; process instrumentation; low-voltage systems; voice and data communications systems; roadway and transit lighting, signaling, and fiber optic lines; computerized traffic control systems, and signal and communication equipment; heating, ventilation, air conditioning, refrigeration, and geothermal solutions; clean-room process ventilation systems; fire protection and suppression systems; plumbing, process, and high-purity piping systems; controls and filtration systems; water and wastewater treatment systems; central plant heating and cooling systems; crane and rigging services; millwright services; and steel fabrication, erection, and welding services. The company also provides building services that covers commercial and government site-based operations and maintenance; facility management, maintenance, and services; energy efficiency retrofit services; military base operations support services; services for indoor air quality; floor care and janitorial services; landscaping, lot sweeping, and snow removal services; vendor management and call center services; installation and support for building systems; program development, management, and maintenance for energy systems; technical consulting and diagnostic services; infrastructure and building projects; modification and retrofit projects; and other building services, including reception, security, and catering services. In addition, it offers refinery turnaround planning and engineering; welding; overhaul and maintenance; instrumentation and electrical; and renewable energy services. The company was incorporated in 1987 and is headquartered in Norwalk, Connecticut.

PetroChina stock logo

PetroChina NYSE:PTR

PetroChina Company Limited, together with its subsidiaries, engages in a range of petroleum related products, services, and activities in Mainland China and internationally. It operates through Exploration and Production, Refining and Chemicals, Marketing, and Natural Gas and Pipeline segments. The Exploration and Production segment engages in the exploration, development, production, and marketing of crude oil and natural gas. The Refining and Chemicals segment refines crude oil and petroleum products; and produces and markets primary petrochemical products, derivative petrochemical products, and other chemical products. The Marketing segment is involved in marketing of refined products and trading business. The Natural Gas and Pipeline segment engages in the transmission of natural gas, crude oil, and refined products; and sale of natural gas. As of December 31, 2021, the company had a total length of 26,076 km, including 17,329 km of natural gas pipelines, 7,340 km of crude oil pipelines, and 1,407 km of refined product pipelines. The company is also involved in the exploration, development, and production of oil sands and coalbed methane; trading of crude oil and petrochemical products; storage, chemical engineering, storage facilities, service station, and transportation facilities and related businesses; and production and sales of basic and derivative chemical, and other chemical products. The company was founded in 1999 and is headquartered in Beijing, the People's Republic of China. PetroChina Company Limited is a subsidiary of China National Petroleum Corporation.